Bioorganic and Medicinal Chemistry Letters p. 3182 - 3185 (2010)
Update date:2022-08-04
Topics:
Velaparthi, Upender
Saulnier, Mark G.
Wittman, Mark D.
Liu, Peiying
Frennesson, David B.
Zimmermann, Kurt
Carboni, Joan M.
Gottardis, Marco
Li, Aixin
Greer, Ann
Clarke, Wendy
Yang, Zheng
Menard, Krista
Lee, Francis Y.
Trainor, George
Vyas, Dolatrai
A series of 3-[6-(4-substitued-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one were synthesized to modulate CYP3A4 inhibition and improve aqueous solubility of our prototypical compound BMS-536924 (1), while maintaining potent IGF-1R inhibitory activity. Structure-activity and structure-solubility studies led to the identification of BMS-577098 (27), which demonstrates oral in vivo efficacy in animal models. The improvement was achieved by replacing morpholine with more polar bio-isoster piperazine and modulating the basicity of distal nitrogen with appropriate substitutions.
View Morewebsite:http://www.u-chemo.com
Contact:+86-21-61558312
Address:Dong Fang Road,
Contact:+86-633-8332928
Address:No.1,Huanghai Yilu.Rizhao,Shandong
website:http://www.gbxfsilicones.com/
Contact:86-25-68900673
Address:He Country Provincial Fine Chemical Industrial Park of Chaohu city,Anhui province,China
Xuzhou Tianrun Chemical Co.,Ltd
website:http://www.tianrunchem.cn
Contact:86-516-83832636
Address:fuxing road
Shijiazhuang Sdyano Fine Chemical Co., Ltd
Contact:+86-311-89830448
Address:NO.48 Ta Nan Road,Yuhua District,Shijiazhuang,Hebei,China
Doi:10.1021/ja00528a053
(1980)Doi:10.1271/bbb1961.44.1009
(1980)Doi:10.1002/ardp.19342721017
(1934)Doi:10.1039/b204655p
(2002)Doi:10.1246/cl.1980.449
(1980)Doi:10.1016/S0040-4020(01)93275-2
(1981)